Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema

Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema

Shanshan Gao, Baocheng Tian, Jingtian Han, Jing Zhang, Yanan Shi, Qingzhi Lv, Keke LiSchool of Pharmacy, Binzhou Medical University, Yantai, People’s Republic of chinaBackground: Nanostructured lipid carriers (NLCs) are emerging as attractive drug carriers in transdermal drug delivery. The...

Full description

Bibliographic Details
Main Authors:	Gao S, Tian B, Han J, Zhang J, Shi Y, Lv Q, Li K
Format:	Article
Language:	English
Published:	Dove Medical Press 2019-08-01
Series:	International Journal of Nanomedicine
Subjects:	lornoxicam nanostructured lipid carriers cell penetrating peptides transdermal drug delivery anti-inflammatory effect
Online Access:	https://www.dovepress.com/enhanced-transdermal-delivery-of-lornoxicam-by-nanostructured-lipid-ca-peer-reviewed-article-IJN

Similar Items

Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery
by: Gönüllü Ümit, et al.
Published: (2015-03-01)

Lornoxicam-Loaded Cubosomes: - Preparation and In vitro Characterization.
by: Rasha Saadi Younus Alkawak, et al.
Published: (2022-06-01)

Transdermal Delivery of Lornoxicam Hybrid Nanogel: Design, Preparation, Characterization, and In-Vitro Diffusion Evaluation
by: Hayder Kadhim Drais
Published: (2023-10-01)

Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout
by: Zakir Ali, et al.
Published: (2022-11-01)

Design and evaluation of lornoxicam bilayered tablets for biphasic release
by: Songa Ambedkar Sunil, et al.
Published: (2012-12-01)

Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam in irradiated rats
by: Saud Bawazeer, et al.
Published: (2020-01-01)

Nebivolol Hydrochloride Loaded Nanostructured Lipid Carriers as Transdermal Delivery System: Part 1: Preparation, Characterization and In Vitro Evaluation
by: Esraa Ghazy, et al.
Published: (2016-12-01)

Advance in transdermal delivery of calcitonin using nanostructured lipid carrier-based emulgel
by: Zahrotunisa, et al.
Published: (2023-01-01)

Nanostructured lipid carriers mediated transdermal delivery of trandolapril as an impeccable therapeutic approach against hypertension: Development, characterization and in vivo evaluation
by: Ramankit Jaiswal, et al.
Published: (2023-05-01)

Lornoxicam use to reduce the pain associated with propofol injection
by: Nihal Başak, et al.
Published: (2017-01-01)

Kinetic Study of Lornoxicam Hydrolysis
by: sawsan hasan hammodi, et al.
Published: (2020-02-01)

Nanostructured Lipid Carrier–Mediated Transdermal Delivery of Aceclofenac Hydrogel Present an Effective Therapeutic Approach for Inflammatory Diseases
by: Neeraj K. Garg, et al.
Published: (2021-09-01)

The synergistic antinociceptive effect of lornoxicam in combination with tramadol
by: Amela Saračević, et al.
Published: (2013-12-01)

Corrigendum: Nanostructured lipid carrier–mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases
by: Neeraj K. Garg, et al.
Published: (2022-08-01)

Acupuncture versus Lornoxicam in the Treatment of Acute Renal Colic: A Randomized Controlled Trial
by: Zhang X, et al.
Published: (2021-11-01)

Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system
by: Zhao X, et al.
Published: (2018-12-01)

Lornoxicam-Loaded Chitosan-Decorated Nanoemulsion: Preparation and In Vitro Evaluation for Enhanced Transdermal Delivery
by: Rahman Ullah Khan, et al.
Published: (2022-05-01)

Comparing Early Postoperative Period Analgesic Effect of Dexketoprofene Trometamol and Lornoxicam in Mediastinoscopy Cases
by: Gonul Sagiroglu
Published: (2011-04-01)

RP-HPLC assay method development for Paracetamol and Lornoxicam in combination and characterization of oxidative degradation products of Lornoxicam
by: Jain Pritam S., et al.
Published: (2013-01-01)

Comparison of tramadol and lornoxicam in intravenous regional anesthesia: a randomized controlled trial
by: Hande Çelik, et al.
Published: (2016-02-01)

Comparison of tramadol and lornoxicam for the prevention of postoperative catheter-related bladder discomfort: a randomized controlled trial
by: Xin Liao, et al.
Published: (2023-06-01)

Compritol-Based Nanostrucutured Lipid Carriers (NLCs) for Augmentation of Zolmitriptan Bioavailability via the Transdermal Route: In Vitro Optimization, Ex Vivo Permeation, In Vivo Pharmacokinetic Study
by: Doaa H. Hassan, et al.
Published: (2022-07-01)

Immunomodulatory Effects of the Cyclooxygenase Inhibitor Lornoxicam on Phenotype and Function of Camel Blood Leukocytes
by: Jamal Hussen, et al.
Published: (2021-07-01)

Design and Optimization of Lornoxicam Dispersible Tablets Using Quality by Design (QbD) Approach
by: Nawaf Almotairi, et al.
Published: (2022-11-01)

Effects of Omega-3 Co-Administered with Therapeutic Dose of lornoxicam on Male Rats' Liver
by: Israa A. Majeed, et al.
Published: (2019-12-01)

Effects of lornoxicam and intravenous ibuprofen on erythrocyte deformability and hepatic and renal blood flow in rats
by: Arpacı H, et al.
Published: (2016-08-01)

Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations
by: Aziz Unnisa, et al.
Published: (2023-08-01)

Comparison between lornoxicam quick-release and parecoxib for post-operative analgesia after laparoscopic cholecystectomy: A prospective randomized, placebo-controlled trial
by: Irene Kouroukli, et al.
Published: (2013-01-01)

Can the preemptive use of lornoxicam or paracetamol prevent pain after inguinal hernia repair? A randomized prospective double-blind placebo controlled trial
by: Alp Alptekin, et al.
Published: (2022-01-01)

A validated stability-indicating RP-HPLC method for paracetamol and lornoxicam: Application to pharmaceutical dosage forms
by: Karunakaran Kulandaivelu, et al.
Published: (2014-01-01)

Development of ibuprofen-loaded nanostructured lipid carrier-based gels: characterization and investigation of in vitro and in vivo penetration through the skin
by: Sütő B, et al.
Published: (2016-03-01)

Enhanced Transdermal Delivery of Pranoprofen Using a Thermo-Reversible Hydrogel Loaded with Lipid Nanocarriers for the Treatment of Local Inflammation
by: María Rincón, et al.
Published: (2021-12-01)

β- Galactosidase mediated release characteristics of lornoxicam loaded guar gum microspheres: evaluation and product development
by: Abdesh Singh, et al.
Published: (2015-12-01)

Assessment of lornoxicam as a mouth dissolving film in management of post extraction pain-A randomized control trial
by: M Aparna Vijayan, et al.
Published: (2022-01-01)

Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment
by: Rui Huang, et al.
Published: (2018-01-01)

The Effect of Nanobubbles on Transdermal Applications
by: Athanasios Ch. Mitropoulos, et al.
Published: (2023-09-01)

Design and dermatokinetic appraisal of lornoxicam-loaded ultrafine self-nanoemulsion hydrogel for the management of inflammation: In vitro and in vivo studies
by: Saleh A. Al-Suwayeh, et al.
Published: (2023-06-01)

Recent Advances in Microneedle Platforms for Transdermal Drug Delivery Technologies
by: Sipho Mdanda, et al.
Published: (2021-07-01)

Bilosomes as Promising Nanovesicular Carriers for Improved Transdermal Delivery: Construction, in vitro Optimization, ex vivo Permeation and in vivo Evaluation
by: Ahmed S, et al.
Published: (2020-12-01)

Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil
by: Rajinikanth PS, et al.
Published: (2016-10-01)